Porcilis Pesti

RSS

Withdrawn

This medicine's authorisation has been withdrawn

adjuvanted vaccine against classical swine fever
MedicineVeterinaryWithdrawn

Italian is available via eTranslation, the European Commission's machine translation service.

Translate to Italian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Porcilis Pesti has been withdrawn at the request of the marketing authorisation holder

български (BG) (389.2 KB - PDF)

Visualizza

español (ES) (186.61 KB - PDF)

Visualizza

čeština (CS) (318.5 KB - PDF)

Visualizza

dansk (DA) (190.05 KB - PDF)

Visualizza

Deutsch (DE) (357.3 KB - PDF)

Visualizza

eesti (ET) (186.1 KB - PDF)

Visualizza

ελληνικά (EL) (390.9 KB - PDF)

Visualizza

français (FR) (186.87 KB - PDF)

Visualizza

italiano (IT) (186.4 KB - PDF)

Visualizza

latviešu (LV) (489.86 KB - PDF)

Visualizza

lietuvių (LT) (299.13 KB - PDF)

Visualizza

magyar (HU) (476.92 KB - PDF)

Visualizza

Nederlands (NL) (186.4 KB - PDF)

Visualizza

polski (PL) (512.21 KB - PDF)

Visualizza

português (PT) (186.65 KB - PDF)

Visualizza

română (RO) (294.11 KB - PDF)

Visualizza

slovenčina (SK) (313.22 KB - PDF)

Visualizza

slovenščina (SL) (305.31 KB - PDF)

Visualizza

suomi (FI) (186.2 KB - PDF)

Visualizza

svenska (SV) (200.67 KB - PDF)

Visualizza

Product information

български (BG) (857.85 KB - PDF)

Visualizza

español (ES) (220.29 KB - PDF)

Visualizza

čeština (CS) (416.9 KB - PDF)

Visualizza

dansk (DA) (226.72 KB - PDF)

Visualizza

Deutsch (DE) (430.62 KB - PDF)

Visualizza

eesti (ET) (269.28 KB - PDF)

Visualizza

ελληνικά (EL) (854.2 KB - PDF)

Visualizza

français (FR) (249.26 KB - PDF)

Visualizza

italiano (IT) (226.44 KB - PDF)

Visualizza

latviešu (LV) (692.49 KB - PDF)

Visualizza

lietuvių (LT) (322.35 KB - PDF)

Visualizza

magyar (HU) (651.75 KB - PDF)

Visualizza

Malti (MT) (473.32 KB - PDF)

Visualizza

Nederlands (NL) (223.73 KB - PDF)

Visualizza

polski (PL) (531.76 KB - PDF)

Visualizza

português (PT) (222.35 KB - PDF)

Visualizza

română (RO) (323.19 KB - PDF)

Visualizza

slovenčina (SK) (437.6 KB - PDF)

Visualizza

slovenščina (SL) (427.77 KB - PDF)

Visualizza

suomi (FI) (224.06 KB - PDF)

Visualizza

svenska (SV) (286.33 KB - PDF)

Visualizza

Íslenska (IS) (223.38 KB - PDF)

Visualizza

norsk (NO) (282.92 KB - PDF)

Visualizza
Latest procedure affecting product information:R/0011
16/09/2011

български (BG) (257.17 KB - PDF)

Visualizza

español (ES) (190.85 KB - PDF)

Visualizza

čeština (CS) (218.43 KB - PDF)

Visualizza

dansk (DA) (191.13 KB - PDF)

Visualizza

Deutsch (DE) (342.19 KB - PDF)

Visualizza

eesti (ET) (189.44 KB - PDF)

Visualizza

ελληνικά (EL) (235.88 KB - PDF)

Visualizza

français (FR) (190.16 KB - PDF)

Visualizza

italiano (IT) (174.2 KB - PDF)

Visualizza

latviešu (LV) (388.87 KB - PDF)

Visualizza

lietuvių (LT) (220.48 KB - PDF)

Visualizza

magyar (HU) (366.11 KB - PDF)

Visualizza

Malti (MT) (251.16 KB - PDF)

Visualizza

Nederlands (NL) (189.72 KB - PDF)

Visualizza

polski (PL) (237.03 KB - PDF)

Visualizza

português (PT) (173.99 KB - PDF)

Visualizza

română (RO) (219.79 KB - PDF)

Visualizza

slovenčina (SK) (249.67 KB - PDF)

Visualizza

slovenščina (SL) (239.92 KB - PDF)

Visualizza

suomi (FI) (190.65 KB - PDF)

Visualizza

svenska (SV) (191.41 KB - PDF)

Visualizza

Íslenska (IS) (189.98 KB - PDF)

Visualizza

norsk (NO) (174.66 KB - PDF)

Visualizza

Product details

Name of medicine
Porcilis Pesti
Active substance
Classical Swine Fever Virus (CSFV) -E2 subunit antigen
International non-proprietary name (INN) or common name
adjuvanted vaccine against classical swine fever
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) code
QI09AD04

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

Active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of Classical Swine Fever, as well as to reduce infection with and excretion of CSF field virus.
The onset of protection is 2 weeks.
The duration of protection is 6 months.

Authorisation details

EMA product number
EMEA/V/C/000046
Marketing authorisation holder
Intervet International BV

Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Marketing authorisation issued
09/06/2000
Revision
12

Assessment history

This page was last updated on

Share this page